Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of parecoxib and paracetamol (also known as acetaminophen) is used for postoperative pain management. This combination leverages the different mechanisms of action of both drugs to provide enhanced analgesia compared to either drug alone in certain surgical settings. ## Pharmacology and Mechanism of Action Parecoxib is a selective COX-2 inhibitor and NSAID (non-steroidal anti-inflammatory drug) that is water-soluble and injectable. It's a prodrug of valdecoxib and works by inhibiting the COX-2 enzyme, which is involved in inflammation and pain signaling[3]. Paracetamol (acetaminophen) has a different mechanism of action. It inhibits COX-1 enzyme activity in the central nervous system and may exert analgesic effects via NMDA receptors in the spinal cord. Part of its effect is thought to be mediated via a central serotonergic mechanism[5]. The combination provides complementary pain relief through these different pathways, potentially offering better analgesia than either drug alone. ## Clinical Efficacy Several studies have investigated the efficacy of this combination: - In patients undergoing total hip arthroplasty, the combination of parecoxib + propacetamol (IV form of paracetamol) reduced cumulative morphine consumption by 59.8% compared to placebo, which was greater than the reduction seen with parecoxib alone (38.9%) or propacetamol alone (26.8%)[1]. - In patients undergoing anterior cruciate ligament (ACL) reconstruction, the combination provided better analgesia and higher patient satisfaction than each drug when used separately[5]. - In mastectomy patients, the combination has been studied for its effectiveness in reducing postoperative acute and subacute breast surgical pain[7]. However, not all studies show significant benefits. In patients undergoing thyroid surgery, one study found no evidence for an additive effect of both non-opioid analgesics[2]. Similarly, in women undergoing uterine curettage, the combination did not produce a clinically important reduction in pain[6]. ## Dosage Common dosages used in clinical studies include: - Parecoxib: 40 mg IV - Paracetamol: 1-2 g IV ## Side Effects and Safety The combination appears to be well-tolerated. While one study noted higher gastrointestinal side effects with parecoxib alone, this was not observed in the combination group[6]. The combination may be particularly valuable in multimodal analgesia approaches to reduce opioid consumption and associated side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on parecoxib + paracetamol.